ISSN 2639-9431
Vol. 1, Issue 3, 2018November 21, 2018 EDT
Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activation
Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activation
Articles in Vol. 1, Issue 3, 2018
Vol. 1, Issue 3, 2018
- Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancerMattaka KhongkowTzu-Yu LiuStacey BartlettWaleed M. HusseinReshma NevagiZhongfan JiaMichael J. MonteiroJames WellsUracha Rungsardthong RuktanonchaiMariusz SkwarczynskiIstvan Toth
- Nanoparticle-Encapsulated Doxorubicin Demonstrates Superior Tumor Cell Kill in Triple Negative Breast Cancer Subtypes Intrinsically Resistant to DoxorubicinAdam FriedmanKenny YeAlicia Rodriguez-GabinJoshua NosanchukJoel FriedmanAlan AlfieriMahantesh NavantiAngelo LandriscinaJamie RosenDavid SchairerJoy MakdisiBrandon AdlerAimee KrauszHayley McDaid
- Specific molecular recognition as a strategy to delineate tumor margin using topically applied fluorescence embedded nanoparticlesWellington PhamShawn BartonBo LiMichael SiutaVaibhav A. JanveJessica SongClinton M. HoltTakumi TomonoMasami UkawaHironori KumagaiEtsuo TobitaKevin WilsonShinji Sakuma
- Plasma samples from mouse strains and humans demonstrate different in vitro susceptibilities to complement activationBarry W NeunGábor SzénásiJános SzebeniMarina Dobrovolskaia
Neun, Barry W, Gábor Szénási, János Szebeni, and Marina Dobrovolskaia. 2018. “Plasma Samples from Mouse Strains and Humans Demonstrate Different in Vitro Susceptibilities to Complement Activation.” Precision Nanomedicine 1 (3): 208–17. https://doi.org/10.33218/prnano1(3).181029.2.